134 related articles for article (PubMed ID: 38001619)
1. Impact of the COVID-19 Pandemic on Staging Oncologic PET/CT Imaging and Patient Outcome in a Public Healthcare Context: Overview and Follow Up of the First Two Years of the Pandemic.
Kohan A; Menon S; Murad V; Mirshahvalad SA; Kulanthaivelu R; Farag A; Ortega C; Metser U; Veit-Haibach P
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001619
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of invasive mediastinal nodal staging versus positron emission tomography staging alone for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.
Schonewolf CA; Verma V; Post CM; Berman AT; Frick MA; Vachani A; Lin C; Simone CB
Lung Cancer; 2018 Mar; 117():53-59. PubMed ID: 28800837
[TBL] [Abstract][Full Text] [Related]
3. An Intensive 18F-Fludeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Strategy of Follow-Up in Patients Treated for Head and Neck Squamous Cell Carcinoma Who Are Clinically Asymptomatic.
Leclère JC; Clément C; Le Pennec R; Maheo C; Gujral DM; Schick U; Le Gal G; Marianowski R; Salaun PY; Abgral R
JAMA Netw Open; 2023 Aug; 6(8):e2326654. PubMed ID: 37526935
[TBL] [Abstract][Full Text] [Related]
4. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
[TBL] [Abstract][Full Text] [Related]
6. Change in cancer diagnosis during the COVID-19 pandemic: Trends estimated from FDG-PET/CT.
Minamimoto R; Hotta M; Okafuji T; Tsutui S; Tsukuda M; Nakayama H; Shida Y; Tajima T
Glob Health Med; 2022 Apr; 4(2):108-115. PubMed ID: 35586769
[TBL] [Abstract][Full Text] [Related]
7. Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer.
Takeuchi S; Khiewvan B; Fox PS; Swisher SG; Rohren EM; Bassett RL; Macapinlac HA
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):906-14. PubMed ID: 24442598
[TBL] [Abstract][Full Text] [Related]
8. Impact of PET staging in limited-stage small-cell lung cancer.
Xanthopoulos EP; Corradetti MN; Mitra N; Fernandes AT; Kim M; Grover S; Christodouleas JP; Evans TL; Stevenson JP; Langer CJ; Lee TT; Pryma DA; Lin LL; Simone CB; Apisarnthanarax S; Rengan R
J Thorac Oncol; 2013 Jul; 8(7):899-905. PubMed ID: 23608814
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy in Follicular Lymphoma Staged by
Karsten IE; Reinartz G; Pixberg M; Kröger K; Oertel M; Friedrichs B; Lenz G; Eich HT
Biomedicines; 2021 May; 9(5):. PubMed ID: 34067779
[TBL] [Abstract][Full Text] [Related]
11. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.
Facey K; Bradbury I; Laking G; Payne E
Health Technol Assess; 2007 Oct; 11(44):iii-iv, xi-267. PubMed ID: 17999839
[TBL] [Abstract][Full Text] [Related]
12. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
[TBL] [Abstract][Full Text] [Related]
13. Consistency and prognostic value of preoperative staging and postoperative pathological staging using
Kajiyama A; Ito K; Watanabe H; Mizumura S; Watanabe SI; Yatabe Y; Gomi T; Kusumoto M
Ann Nucl Med; 2022 Dec; 36(12):1059-1072. PubMed ID: 36264439
[TBL] [Abstract][Full Text] [Related]
14. The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada.
Beers CA; Pond GR; Wright JR; Tsakiridis T; Okawara GS; Swaminath A
Front Oncol; 2023; 13():1210945. PubMed ID: 37681028
[TBL] [Abstract][Full Text] [Related]
15. Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer.
Ercelep O; Alan O; Sahin D; Telli TA; Salva H; Tuylu TB; Babacan NA; Kaya S; Dane F; Ones T; Alkis H; Adli M; Yumuk F
Clin Transl Oncol; 2019 Apr; 21(4):499-504. PubMed ID: 30229391
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with
Risør LM; Clausen MM; Ujmajuridze Z; Farhadi M; Andersen KF; Loft A; Friborg J; Kjaer A
J Nucl Med; 2022 Aug; 63(8):1169-1176. PubMed ID: 34857658
[TBL] [Abstract][Full Text] [Related]
17. Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation.
Dashevsky BZ; Zhang C; Yan L; Yuan C; Xiong L; Liu Y; Liu H; Kong FS; Pu Y
Eur J Hybrid Imaging; 2017; 1(1):8. PubMed ID: 29782599
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery.
Lee H; Choi YL; Kim HK; Choi YS; Kim H; Ahn MJ; Pyo HR; Choi JY
Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686654
[TBL] [Abstract][Full Text] [Related]
19. Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer.
Niikura N; Liu J; Costelloe CM; Palla SL; Madewell JE; Hayashi N; Yu TK; Tokuda Y; Theriault RL; Hortobagyi GN; Ueno NT
Oncologist; 2011; 16(6):772-82. PubMed ID: 21632453
[TBL] [Abstract][Full Text] [Related]
20. Integration of 18-FDG PET/CT in the Initial Work-Up to Stage Head and Neck Cancer: Prognostic Significance and Impact on Therapeutic Decision Making.
Leclere JC; Delcroix O; Rousset J; Valette G; Robin P; Guezennec C; Le Pennec R; Gujral DM; Abgral M; Ollivier L; Marianowski R; Salaun PY; Schick U; Abgral R
Front Med (Lausanne); 2020; 7():273. PubMed ID: 32714934
[No Abstract] [Full Text] [Related]
[Next] [New Search]
